NEPHROPLUS — Nephrocare Health Services Cashflow Statement
0.000.00%
Last trade - 00:00- IN₹60.96bn
- IN₹60.96bn
- IN₹7.56bn
Annual cashflow statement for Nephrocare Health Services, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2023 March 31st | 2024 March 31st | 2025 March 31st | 2026 March 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | PRESS |
| Standards: | IAS | IAS | IAS | — |
| Status: | Final | Final | Final | Final |
| Net Income/Starting Line | -85.9 | 332 | 874 | 975 |
| Depreciation | ||||
| Non-Cash Items | 217 | 241 | 206 | 776 |
| Unusual Items | ||||
| Equity in Net Earnings/Losses | ||||
| Other Non-Cash Items | ||||
| Changes in Working Capital | -487 | -411 | -451 | -331 |
| Change in Accounts Receivable | ||||
| Change in Inventories | ||||
| Change in Other Assets | ||||
| Change in Accounts Payable | ||||
| Change in Other Liabilities | ||||
| Other Operating Cash Flow | ||||
| Cash from Operating Activities | 113 | 723 | 1,353 | 2,326 |
| Capital Expenditures | -716 | -773 | -998 | -1,189 |
| Purchase of Fixed Assets | ||||
| Other Investing Cash Flow Items | -66.4 | 267 | -253 | -2,915 |
| Acquisition of Business | ||||
| Sale of Fixed Assets | ||||
| Sale/Maturity of Investment | ||||
| Purchase of Investments | ||||
| Change in Net Intangibles | ||||
| Other Investing Cash Flow | ||||
| Cash from Investing Activities | -782 | -507 | -1,251 | -4,104 |
| Financing Cash Flow Items | -161 | -165 | -188 | -185 |
| Other Financing Cash Flow | ||||
| Net Issuance / Retirement of Stock | ||||
| Net Issuance / Retirement of Debt | ||||
| Cash from Financing Activities | 600 | 267 | 544 | 1,571 |
| Foreign Exchange Effects | ||||
| Beginning Cash Balance | ||||
| Ending Cash Balance | ||||
| Net Change in Cash | -44.9 | 471 | 647 | -19.3 |